NDC 44087-5000

TEPMETKO

Tepotinib Hydrochloride

TEPMETKO is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Emd Serono, Inc.. The primary component is Tepotinib Hydrochloride.

• Product ID: 44087-5000_0e1caeb4-43fb-4e23-a505-e731e6902e50
• NDC: 44087-5000
• Product Type: Human Prescription Drug
• Proprietary Name: TEPMETKO
• Generic Name: Tepotinib Hydrochloride
• Dosage Form: Tablet
• Route of Administration: ORAL
• Marketing Start Date: 2021-02-03
• Marketing Category: NDA / NDA
• Application Number: NDA214096
• Labeler Name: EMD Serono, Inc.
• Substance Name: TEPOTINIB HYDROCHLORIDE
• Active Ingredient Strength: 225 mg/1
• Pharm Classes: Kinase Inhibitor [EPC],Mesenchymal Epithelial Transition Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA]
• NDC Exclude Flag: N
• Listing Certified Through: 2022-12-31

Packaging

NDC 44087-5000-3

3 BLISTER PACK in 1 CARTON (44087-5000-3) > 10 TABLET in 1 BLISTER PACK

• Marketing Start Date: 2021-02-03
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details